Literature DB >> 30925484

Effect of H2O2 induced oxidative stress (OS) on volatile organic compounds (VOCs) and intracellular metabolism in MCF-7 breast cancer cells.

Yuanling Liu1, Wenwen Li, Yixiang Duan.   

Abstract

Oxidative stress (OS) refers to the process of oxidative damage caused by reactive oxygen species (ROS) and reactive nitrogen species (RNS) accumulated by the organisms or cells during the process of generating and scavenging oxygen free radicals. In this study, an OS model of MCF-7 cells was constructed through H2O2-treatment, which for the first time combined volatile organic compounds (VOCs) and intracellular metabolic analysis for a comprehensive and in-depth study of the OS effect on cell metabolism. The VOCs produced by cells in H2O2-treated groups and control groups were extracted with solid-phase microextraction (SPME) and analyzed by gas chromatography-mass spectrometer (GC-MS). Meanwhile, the intracellular metabolites were extracted by methanol and analyzed by GC-MS coupled with silyl-derivatization. The results indicated 15 VOCs and 29 intracellular metabolites were statistically different (p < 0.05) between the H2O2-treated groups and the control groups. The VOC biomarkers were mainly linear chain alkanes and branched chain alkanes, and they were up-regulated in cells treated by H2O2. The intracellular metabolites with significant changes were mainly fatty acids, amino acids, and organic acids. Most of them, however, were down-regulated under OS state. This study revealed volatile and non-volatile metabolites that influenced by elevated OS in MCF-7 cells, and provided clues for mechanism exploration of exhaled biomarkers, thus promoting the non-invasive prediction of BC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30925484     DOI: 10.1088/1752-7163/ab14a5

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  8 in total

Review 1.  Volatile Organic Compounds Analysis as a Potential Novel Screening Tool for Breast Cancer: A Systematic Review.

Authors:  Michelle Leemans; Pierre Bauër; Vincent Cuzuel; Etienne Audureau; Isabelle Fromantin
Journal:  Biomark Insights       Date:  2022-05-23

2.  Identifying the novel key genes in renal cell carcinoma by bioinformatics analysis and cell experiments.

Authors:  Yeda Chen; Di Gu; Yaoan Wen; Shuxin Yang; Xiaolu Duan; Yongchang Lai; Jianan Yang; Daozhang Yuan; Aisha Khan; Wenqi Wu; Guohua Zeng
Journal:  Cancer Cell Int       Date:  2020-07-21       Impact factor: 6.429

3.  First Insights on the Presence of the Unfolded Protein Response in Human Spermatozoa.

Authors:  Joana Santiago; Joana Vieira Silva; Margarida Fardilha
Journal:  Int J Mol Sci       Date:  2019-11-05       Impact factor: 5.923

4.  Ants detect cancer cells through volatile organic compounds.

Authors:  Baptiste Piqueret; Brigitte Bourachot; Chloé Leroy; Paul Devienne; Fatima Mechta-Grigoriou; Patrizia d'Ettorre; Jean-Christophe Sandoz
Journal:  iScience       Date:  2022-02-22

5.  Sampling and Analysis of Low-Molecular-Weight Volatile Metabolites in Cellular Headspace and Mouse Breath.

Authors:  Theo Issitt; Sean T Sweeney; William J Brackenbury; Kelly R Redeker
Journal:  Metabolites       Date:  2022-06-27

6.  Regulating Effect of Cytochrome b5 Overexpression on Human Breast Cancer Cells.

Authors:  Xin-Yi Tong; Xin-Zhi Yang; Shu-Qin Gao; Xiao-Juan Wang; Ge-Bo Wen; Ying-Wu Lin
Journal:  Molecules       Date:  2022-07-17       Impact factor: 4.927

7.  Identification of breast cancer risk modules via an integrated strategy.

Authors:  Wan Li; Gui Deng; Ji Zhang; Erqiang Hu; Yuehan He; Junjie Lv; Xilin Sun; Kai Wang; Lina Chen
Journal:  Aging (Albany NY)       Date:  2019-12-20       Impact factor: 5.682

8.  Early diagnosis of breast cancer from exhaled breath by gas chromatography-mass spectrometry (GC/MS) analysis: A prospective cohort study.

Authors:  Yu Zhang; Lei Guo; Zhongzhi Qiu; Yang Lv; Guangmin Chen; Enyou Li
Journal:  J Clin Lab Anal       Date:  2020-11-04       Impact factor: 3.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.